The gut microbiome in psoriasis and psoriatic arthritis.


Journal

Best practice & research. Clinical rheumatology
ISSN: 1532-1770
Titre abrégé: Best Pract Res Clin Rheumatol
Pays: Netherlands
ID NLM: 101121149

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 4 5 2020
medline: 21 7 2020
entrez: 4 5 2020
Statut: ppublish

Résumé

This review summarizes existing research on the gut microbiome composition and function in psoriasis and psoriatic arthritis, exploring potential roles in disease pathogenesis, progression, and management. A strong relationship between skin, joint, and gastrointestinal inflammation exists, as demonstrated by an increased prevalence of psoriasis, psoriatic arthritis, and inflammatory bowel disease co-occurring together; however, the link between them has not been fully elucidated. Studies analyzing the gut microbiome in psoriasis and psoriatic arthritis reveal a unique pattern of dysbiosis. With regard to the gut microbiome's role in psoriasis and psoriatic arthritis pathogenesis, we discuss several theories including intestinal permeability, altered immune homeostasis, and imbalance of short- and medium-chain fatty acid-producing bacteria. We also discuss how the gut microbiome affects patient risk of psoriatic arthritis and other serious comorbidities, and how fecal microbes could be used clinically as therapeutic targets or markers of disease.

Identifiants

pubmed: 32360228
pii: S1521-6942(20)30011-5
doi: 10.1016/j.berh.2020.101494
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101494

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have none to disclose.

Auteurs

Bridget Myers (B)

University of California San Francisco Department of Dermatology, San Francisco, CA, USA. Electronic address: Bridget.myers@ucsf.edu.

Nicholas Brownstone (N)

University of California San Francisco Department of Dermatology, San Francisco, CA, USA. Electronic address: Nicholas.brownstone@ucsf.edu.

Vidhatha Reddy (V)

University of California San Francisco Department of Dermatology, San Francisco, CA, USA. Electronic address: Vidhatha.reddy@ucsf.edu.

Stephanie Chan (S)

University of California San Francisco Department of Dermatology, San Francisco, CA, USA. Electronic address: Stephanie.chan@ucsf.edu.

Quinn Thibodeaux (Q)

University of California San Francisco Department of Dermatology, San Francisco, CA, USA. Electronic address: Quinn.thibodeaux@ucsf.edu.

Alexa Truong (A)

University of California Berkeley, Berkeley, CA, USA. Electronic address: Alexatruong13@berkeley.edu.

Tina Bhutani (T)

University of California San Francisco Department of Dermatology, San Francisco, CA, USA. Electronic address: Tina.bhutani@ucsf.edu.

Hsin-Wen Chang (HW)

University of California San Francisco Department of Dermatology, San Francisco, CA, USA. Electronic address: HsinWen.Chang@ucsf.edu.

Wilson Liao (W)

University of California San Francisco Department of Dermatology, San Francisco, CA, USA. Electronic address: wilson.liao@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH